Immucell (ICCC) Inventory Average (2011 - 2026)

Immucell (ICCC) has reported Inventory Average for 16 consecutive years, with $9.2 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Inventory Average rose 17.21% year-over-year to $9.2 million; the trailing twelve-month figure through Jun 2026 stood at $9.2 million (up 17.21% YoY), and the FY2025 full-year result was $8.2 million, up 9.75% from the prior year.
• Inventory Average declined to $9.2 million in Q2 2026 per ICCC's latest filing, from $9.5 million in the prior quarter.
• Across five years, Inventory Average topped out at $9.5 million in Q4 2025 and bottomed at $3.3 million in Q1 2022.
• Historically, Inventory Average has averaged $7.0 million across 5 years, with a median of $7.3 million in 2024.
• The sharpest annual moves came in 2022 and 2024: Inventory Average surged 97.26% in 2022, then dropped 4.11% in 2024.
• Over 5 years, Inventory Average stood at $5.7 million in 2022, then surged by 33.82% to $7.6 million in 2023, then decreased by 4.11% to $7.3 million in 2024, then jumped by 30.85% to $9.5 million in 2025, then decreased by 3.79% to $9.2 million in 2026.
• According to Business Quant data, Inventory Average over the past three periods registered $9.2 million, $9.5 million, and $9.0 million for Q2 2026, Q4 2025, and Q3 2025 respectively.